Congenital stationary night blindness (CSNB) is a defect in night vision, which is present at birth. Night blindness may occur as a distinct genetic disease entity, or as part of more complex inherited disorders, among them retinitis pigmentosa.
Clinical and genetic heterogeneity has been suggested for both autosomal dominant and X linked CSNB (CSNBX). The clinical heterogeneity of CSNBX in patients, even within the same family, is the result of subtle variation of the involvement of rods or cones, or both, in the disease, which can be visualised through dark adaptation curves and electroretinogram (ERG) amplitudes.l" Three clinical forms of CSNBX have been distinguished: complete CSNB (CSNB1), incomplete CSNB (CSNB2), and Aland Island eye disease (AIED). CSNB1 is frequently associated with high myopia. We showed recently that the clinical expression of CSNB1 and CSNB2 appears not to correlate with distinct disease genes (Tijmes et al, manuscript submitted).
So far, three confirmed positions for CSNBX genes have been reported, all proximal to the reference locus DXS7 on proximal Xp. Multiple linkage studies have located a CSNBX gene to the chromosomal interval between DXS7 and DXS426,'-9 while another gene has been located even more proximal to the latter chromosomal interval.9 The localisation of the AIED gene has been refined to between DXS7 and DXS255.'`-" However, we recently suggested that yet another CSNBX gene may be located in Xp2 1.1, distal to the DXS7 reference locus." Here, we describe a linkage analysis in a new family with CSNBX, thereby providing conclusive evidence for a distinct CSNBX gene locus in Xp21.1.
Subjects and methods

CASES AND CONTROLS
Over the years, all members of pedigree P520 (fig 1) came to our department for ophthalmic diagnosis and genetic counselling. More recently, ophthalmic re-examination was performed, and blood was collected for DNA studies after informed consent. All pedigree members who took part in this study underwent an ophthalmological and electrophysiological examination.
Ophthalmological examination included best refracted visual acuity in both eyes, slit lamp examination, and direct and indirect fundoscopy in full mydriasis. Colour vision was examined with the Panel D-1 5 (unsaturated) and the Ishihara test. Affected males were examined by kinetic Goldmann perimetry using V-4-e, III-4-e, and I-4-e targets.
Flash 
Results
CASES AND CONTROLS
The detailed clinical results of members of pedigree P23340 have been described elsewhere (Tijmes et al, manuscript submitted).
From pedigree P520, five affected males (cases), seven obligate carriers, and three unaffected males (controls) were examined. The cases (aged from 16 to 64 years) had all experienced night blindness from very early childhood onwards. All had a reduced visual acuity which showed no deterioration during lifetime. All cases had myopia (ranging from S-3 to S-9) and a fine horizontal nystagmus.
Fundoscopically, we did not find a pale optic disc, attenuated vessels, bone corpuscles, or retinal pigment epithelium changes in any of the affected males. Visual field tests showed no concentric narrowing or scotomas. Two patients had a slightly concentric restriction of their visual field. However, these patients did not have the field defects seen in retinitis pigmentosa, but a small restriction because oftheir high myopia (-9). Colour vision was normal in all members of the pedigree examined.
None of the cases experienced deterioration, during an average follow up period offive years, of their visual acuity or ERG recordings. The ERGs of the patients seemed to lack any rod component, and showed the typical Schubert Bornschein "negative" wave shape, classifying all cases into the category of complete CSNBX.' The cone ERG of all cases was not reduced in amplitude, but showed a slightly altered wave shape: the a wave was broader and the b wave was reduced. Dark adaptation showed absence of a rod mediated branch.
The six obligate carriers and one possible carrier had a normal visual acuity, no myopia, and no abnormalities on ERG. The controls also had normal visual acuities and normal ERG. In conclusion, the data from these examinations strongly support the segregation of (complete) CSNBX in this family. Apart from the night blindness, as shown by the dark adaptation curves, there were no clinical or electrophysiological signs of retinitis pigmentosa.
DNA ANALYSIS
The CSNBX family P520 was studied with 11 markers from proximal Xp. Very preliminary data on a few members of this family were reported by Li et al. 7 Assuming the fewest number of recombinants, the most The results shown in fig 2 indicate that the CSNBX gene in families P520 and P23430 is localised distal to DXS7, with a probability of more than 1000:1. Since the DYSII locus and CSNBX yielded highly significant two point lod scores (table 1) , it was of interest to locate CSNBX relative to this locus as well. Fig 3 shows that CSNBX most likely is localised proximal to DYSII with a probability of at least 100:1. If DXS1110 was included in the analysis, multipoint lod scores favouring the interval DYSII-DXS228 as the most likely chromosomal region for CSNB exceeded 6.1, while other positions of CSNBX became even less likely. edigree P520 and pedigree P23430, which Discussion previously been described by us,'3 are pre-We previously suggested the presence of a disted in table 1. tinct CSNBX gene in band Xp21.1 of the lultipoint lod scores were carried out with human X chromosome.'3 However, that hyerent sets of markers. Two of the most pothesis was based on an observation in a single rmative results are shown. The position of pedigree. A rare chromosomal rearrangement, NBX was independently tested against the a double crossover or another genetic mechy" loci DXS7 (fig 2) and DYS 1 (fig 3) on anism leading to biased results in that pedigree, ackground map of loci flanking these loci. could not be excluded.
In this paper, we report a second family in which the CSNBX gene maps to Xp2 1.1.
ICSNBX2I
Combining our results with our previously published Xp2 1.1 linked pedigree, we present here conclusive evidence for a second CSNBX locus on the short arm of the human X chromosome. Our data, combined with other published data, yield the chromosomal gene/marker order Xpter-DXS45 1 -DMD-DYS 1 -(DXS 11 This study was supported by The Netherlands Society for Prevention of Blindness, and the Retinitis Pigmentosa Foundation of The Netherlands.
